By Business/Source
Currency:USD
2026/Q1
Stock NameRevenueRatio
Discovering and developing engineered antibody therapeutics to treat patients with cancer and4.52M100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States125.58M100.00%